Multidisciplinary Association For Psychedelic Studies, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Pilot Study of the Safety and Efficacy of Four Different Potencies of Smoked Marijuana in 76 Veterans With PTSD

Phase 2

Completed

Conditions: Posttraumatic Stress Disorder

Interventions: Drug: High THC cannabis
Drug: High CBD cannabis
Drug: THC/CBD cannabis
Drug: Placebo cannabis

First Posted Date: 2016-05-03

Last Posted Date: 2023-07-12

Lead Sponsor: Multidisciplinary Association for Psychedelic Studies

Target Recruit Count: 80

Registration Number: NCT02759185

Locations: 🇺🇸
Scottsdale Research Institute, Phoenix, Arizona, United States

Psilocybin-Assisted Psychotherapy for Anxiety in People With Stage IV Melanoma

Phase 2

Withdrawn

Conditions: Stage IV Melanoma
Anxiety

Interventions: Drug: psilocybin

First Posted Date: 2009-09-18

Last Posted Date: 2023-12-26

Lead Sponsor: Multidisciplinary Association for Psychedelic Studies

Registration Number: NCT00979693

Locations: 🇺🇸
Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida, United States

Lysergic Acid Diethylamide (LSD)-Assisted Psychotherapy in People With Illness-related Anxiety

Phase 2

Completed

Conditions: Anxiety

Interventions: Drug: 20 mcg LSD
Drug: 200 mcg LSD
Behavioral: Therapy

First Posted Date: 2009-06-15

Last Posted Date: 2023-07-12

Lead Sponsor: Multidisciplinary Association for Psychedelic Studies

Target Recruit Count: 12

Registration Number: NCT00920387

Locations: 🇨🇭
Private Practices of Peter Gasser MD, Solothurn, Switzerland

Prev
1
Next

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy